{
    "title": "109_s2255",
    "content": "The Act titled \"Medicare Drug Formulary Protection Act\" allows for the removal of covered Part D drugs from the prescription drug plan formulary. The Medicare Drug Formulary Protection Act allows the PDP sponsor of a prescription drug plan to impose restrictions on coverage starting in 2006. Starting in 2006, the PDP sponsor of a prescription drug plan cannot remove a covered part D drug from the plan formulary or restrict its coverage. The PDP sponsor of a prescription drug plan cannot impose limitations on drug coverage, except at the beginning of each plan year or as permitted by the Secretary for new therapeutic uses or newly covered part D drugs. The PDP sponsor of a prescription drug plan may not remove a covered part D drug for newly enrolled individuals. The PDP sponsor of a prescription drug plan cannot remove a covered part D drug or restrict its coverage for individuals who enroll after the date of enactment. This includes limitations like preferred status, step therapy, or quantity restrictions. The PDP sponsor of a prescription drug plan cannot restrict coverage for individuals who enroll after the date of enactment, including limitations like preferred status, step therapy, prior authorization, or quantity limitation, except as permitted by the Secretary for new therapeutic uses and newly covered drugs. The PDP sponsor cannot limit coverage for new enrollees, except as allowed by the Secretary for new therapeutic uses and newly covered drugs, including exceptions for brand name drugs with generic equivalents. The PDP sponsor cannot restrict coverage for brand name drugs with generic equivalents approved under section 505(j) of the Food and Drug Cosmetic Act. The PDP sponsor cannot restrict coverage for brand name drugs that go off-patent, have FDA clinical warnings, or are determined to be ineffective. The PDP sponsor must notify the Secretary and affected parties of any removal or change in drug coverage restrictions or limitations. The PDP sponsor must provide annual notice of changes in formulary and coverage restrictions to all parties involved. Each PDP sponsor offering a prescription drug plan must provide enrollees with annual notice of any changes in formulary or coverage restrictions that will take effect for the plan year. The PDP sponsor must notify enrollees of any changes in formulary or coverage restrictions for the upcoming plan year, with the amendment applying to future annual coordinated election periods."
}